Latest filing published 12 Nov 2021 for Doximity, Inc..
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +6.6%Entry US$140.20 · Close at T+365 US$149.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Morgenthaler Venture Partners IX LP: trading record in brief
This profile gathers the share dealings of Morgenthaler Venture Partners IX LP across 4 companies, led by Ra Pharmaceuticals, Inc., Calithera Biosciences, Inc. and Doximity, Inc. In total, 12 filings cover trades dated from 7 October 2014 to 12 November 2021.
Both buying and selling appear: 2 purchases worth €5.9M, against 1 sale worth €4,024. Netting one side against the other leaves €5.9M of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.
The newest entry dates from 12 November 2021: a transaction, in Doximity, Inc. The latest purchase dates back some time: it was published 3,661 days ago, on 31 October 2016. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Morgenthaler Venture Partners IX LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,535,175 shares0Class A Common StockSEC:0001104659-21-138151:1
- 17,070,350 shares0Class A Common StockSEC:0001104659-21-138151:0
- 921,348 sharesCommon StockSEC:0000899243-18-029477:0
- 61,342 sharesCommon StockSEC:0000899243-18-029477:1
- 1,392,130 sharesCommon StockSEC:0001104659-16-153349:2
- 523,438 sharesCommon StockSEC:0001104659-16-153349:3
- 486,919 sharesCommon StockSEC:0001104659-16-153349:4
- 63,019 shares@ US$0.070.1% of flowCommon StockSEC:0001104659-16-153349:0
- 340 shares@ US$13.000.1% of flowCommon StockSEC:0001104659-16-153349:1
- 263,538 shares@ US$13.0099.7% of flowCommon StockSEC:0001104659-16-153349:5Canonical exit: 29 Jan 2017 (T+90)
- 1,811,915 shares@ US$10.00COMMON STOCKSEC:0001209191-14-062658:0
- 350,000 shares@ US$10.00COMMON STOCKSEC:0001209191-14-062658:1Canonical exit: 5 Jan 2015 (T+90)
12 of 12 declarations
